Innoviva Inc

INVANASDAQ · USD
20.98USD0.00 (-0.29%)
957

Innoviva Inc (INVA) Options Open Interest

INVA options open interest is 1,163 contracts. The 2-week average daily volume is 108 contracts across the chain.

Read more

Monitoring INVA open interest helps you see where real money is positioned on Innoviva Inc's options and which strikes are attracting the most commitment from traders. Innoviva Inc's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor INVA options open interest in real time and find the strikes that matter.

Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising INVA options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Innoviva Inc to settle.

Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium bromide (UMEC), with a LABA, and VI; and TRELEGY ELLIPTA, a once-daily combination medicine consisting of an ICS, LAMA, and LABA. Innoviva, Inc. has a strategic partnership with Sarissa Capital Management LP.

The company has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California.

Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where INVA open interest is concentrated. Our scanner maps Innoviva Inc's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Innoviva Inc's options open interest as the signal it is, not as an afterthought.

2026-10-16
Calls
22.500.750.7555%+0.373255
20.000.404.502.4580%+0.646710
12.506.3011.008.6517%+1.00000
15.003.808.506.1510%+1.00000
17.502.056.004.0372%+0.85760
Puts
12.503.803.80434%-0.14950
15.001.751.75215%-0.18860
17.501.151.15124%-0.23090
20.001.151.1575%-0.34950
22.500.554.802.6883%-0.55950

As of September 21, 2026

Follow the money

Track INVA open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.

Start your 14-day free trial